The global empty capsules market was valued at USD 3.82 billion in 2023 and is projected to reach USD 4.97 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030. This growth is supported by several significant factors, primarily the rising geriatric population worldwide, which has created greater demand for effective and easily consumable medications. Elderly patients often face difficulties swallowing tablets or consuming complex dosage forms, which has led to a strong preference for capsules due to their ease of ingestion, smooth texture, and faster dissolution rate compared to tablets and other solid dosage forms.

Furthermore, consumer preference is shifting toward capsules, not only because they are easier to swallow but also because they offer quicker therapeutic action. Capsules are known to have higher bioavailability, which means that a greater proportion of the active ingredient is absorbed into the bloodstream, resulting in more effective treatment outcomes. This advantage has made capsules the dosage form of choice in a wide range of therapies.

In addition, capsules provide a unique advantage by being suitable for both solid and liquid formulations, enabling pharmaceutical and nutraceutical companies to expand the variety of products they can deliver in capsule form. This versatility has increased their adoption across the pharmaceutical, nutraceutical, and cosmeceutical industries, which are experiencing continuous growth due to rising health awareness, preventive healthcare practices, and increasing demand for dietary supplements.

Another major driver of the empty capsule market is their flexibility in drug delivery. Capsules can be customized for immediate, delayed, or sustained release, offering manufacturers greater control over drug release mechanisms. This ability to tailor dosage forms to specific therapeutic needs has boosted their adoption in antibiotics, antibacterials, vitamins, and dietary supplements, among others.

Key Market Trends & Insights:

• Regional Trends: North America dominated the global empty capsules market in 2023, accounting for a 34.7% revenue share. This dominance can be attributed to the presence of a well-established pharmaceutical industry, strong nutraceutical demand, advanced healthcare infrastructure, and widespread use of capsules in drug formulations. The Asia Pacific market is expected to register the fastest CAGR during the forecast period. Factors such as increasing investments in the healthcare sector, a large patient base, growing health awareness, and the rapid expansion of nutraceutical consumption in countries like China, India, and Japan are driving this growth.
• By Capsule Type: The gelatin capsule segment was the market leader in 2023, holding a 73.5% revenue share. Gelatin capsules remain widely used due to their low cost, ease of manufacturing, and proven safety profile in pharmaceutical applications. However, the non-gelatin capsule segment is expected to expand at the fastest CAGR during the forecast period. This surge is driven by rising consumer demand for vegetarian and vegan alternatives, as well as growing preference for plant-based and allergen-free capsule shells in both pharmaceuticals and nutraceuticals.
• By Application: The antibiotic and antibacterial drugs segment dominated the market in 2023, contributing the largest revenue share. The high prevalence of infectious diseases and the rising use of antibiotic therapies worldwide support the demand for empty capsules in this category. The vitamins and dietary supplements segment is projected to grow at the fastest CAGR, fueled by the global trend of preventive healthcare, increased use of dietary supplements, and consumer inclination toward maintaining wellness and immunity.
• By End-Use Industry: The pharmaceutical segment accounted for the largest share of the market in 2023. The widespread use of capsules in prescription medicines, over-the-counter (OTC) drugs, and generic formulations underpins this dominance. The nutraceutical segment, however, is expected to grow at the fastest CAGR throughout the forecast period. The rising popularity of dietary supplements, functional foods, and herbal products among health-conscious consumers is driving capsule demand in this sector.

Order a free sample PDF of the Empty Capsules Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2023 Market Size: USD 3.82 Billion
• 2030 Projected Market Size: USD 4.97 Billion
• CAGR (2024-2030): 3.8%
• North America: Largest market in 2023
• Asia Pacific: Fastest growing market

Key Players

The following are the leading companies in the empty capsules market. These companies collectively hold the largest market share and dictate industry trends.

• Bright Pharma Caps Inc.
• Lonza Group
• Qualicaps
• HealthCaps India Ltd
• Dun & Bradstreet, Inc. (Shanxi JC Biological Technology Co. Ltd)
• ACG
• Medi-Caps Ltd
• Suheung
• capsCanada Corporation

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global empty capsules market is on a steady growth trajectory, supported by rising demand from the pharmaceutical, nutraceutical, and cosmeceutical industries. Factors such as the growing geriatric population, increasing consumer preference for capsules over tablets, and the versatility of capsules in delivering both solid and liquid formulations are key drivers shaping the market. While gelatin capsules currently dominate due to their widespread use and cost-effectiveness, the non-gelatin segment is gaining momentum, fueled by the shift toward vegetarian and vegan alternatives. Additionally, strong demand for vitamins, dietary supplements, and preventive healthcare solutions is accelerating market expansion, particularly in emerging economies. With technological advancements, changing consumer preferences, and a strong focus on health and wellness, the empty capsules market is expected to play a critical role in the future of drug delivery and supplement formulations worldwide.